D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 91 Citations 56,280 474 World Ranking 7157 National Ranking 696

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Surgery
  • Health care

Mark Sculpher mostly deals with Health care, Randomized controlled trial, Economic evaluation, Cost-effectiveness analysis and Health technology. His study connects Management science and Health care. His Randomized controlled trial research is multidisciplinary, incorporating perspectives in Placebo, Physical therapy, Arthroplasty and Hazard ratio.

His Economic evaluation research integrates issues from Psychological intervention, Key and Engineering ethics. His research in Cost-effectiveness analysis intersects with topics in Actuarial science and Econometrics. His Surgery study combines topics from a wide range of disciplines, such as Internal medicine and Clinical trial.

His most cited work include:

  • Methods for the Economic Evaluation of Health Care Programmes (7819 citations)
  • Decision Modelling for Health Economic Evaluation (1658 citations)
  • Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine (1049 citations)

What are the main themes of his work throughout his whole career to date?

His main research concerns Economic evaluation, Health care, Randomized controlled trial, Quality-adjusted life year and Cost-effectiveness analysis. The various areas that he examines in his Economic evaluation study include Health technology, Management science and Health economics. His Health care research incorporates elements of Psychological intervention, Public economics, Actuarial science, Risk analysis and Opportunity cost.

The study incorporates disciplines such as Physical therapy, Quality of life and Clinical trial in addition to Randomized controlled trial. His work carried out in the field of Quality-adjusted life year brings together such families of science as Surgery and Intensive care medicine. His research in Internal medicine is mostly focused on Myocardial infarction.

He most often published in these fields:

  • Economic evaluation (16.70%)
  • Health care (16.50%)
  • Randomized controlled trial (15.09%)

What were the highlights of his more recent work (between 2016-2021)?

  • Economic evaluation (16.70%)
  • Health care (16.50%)
  • Psychological intervention (12.27%)

In recent papers he was focusing on the following fields of study:

The scientist’s investigation covers issues in Economic evaluation, Health care, Psychological intervention, Public economics and Health economics. He performs multidisciplinary study in Economic evaluation and Context in his work. The concepts of his Health care study are interwoven with issues in Opportunity cost, Personalized medicine and Management science.

His Management science research includes elements of Conceptual framework and Critical appraisal. The Psychological intervention study combines topics in areas such as Actuarial science, Risk analysis, Investment and Intensive care medicine. The Decision model study which covers Expected value of perfect information that intersects with Quality-adjusted life year.

Between 2016 and 2021, his most popular works were:

  • Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial (193 citations)
  • Optimising the Diagnosis of Prostate Cancer in the Era of Multiparametric Magnetic Resonance Imaging: A Cost-effectiveness Analysis Based on the Prostate MR Imaging Study (PROMIS) (84 citations)
  • Developing a Value Framework: The Need to Reflect the Opportunity Costs of Funding Decisions (41 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Surgery
  • Statistics

Mark Sculpher spends much of his time researching Health care, Psychological intervention, Economic evaluation, Value and Cost-effectiveness analysis. His Health care study incorporates themes from Multiple-criteria decision analysis, Management science and Decision analysis. Mark Sculpher works mostly in the field of Psychological intervention, limiting it down to concerns involving Actuarial science and, occasionally, Emerging technologies, Set and Dynamic pricing.

His work often combines Economic evaluation and Context studies. His Value study integrates concerns from other disciplines, such as Cost–utility analysis, Risk analysis and Investment. His studies in Cost-effectiveness analysis integrate themes in fields like Manual therapy, Quality of life, Meta-analysis, Selection bias and Prostate cancer.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Methods for the Economic Evaluation of Health Care Programmes

Michael F. Drummond;Mark J. Sculpher;Karl Claxton;Greg L. Stoddart.
(2015)

19815 Citations

Decision Modelling for Health Economic Evaluation

Andrew Briggs;Karl Claxton;Mark J Sculpher.
(2006)

3107 Citations

Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine

Gillian D. Sanders;Peter J. Neumann;Anirban Basu;Dan W. Brock.
(2016)

1929 Citations

Primary total hip replacement surgery: a systematic review of outcomes and modelling of cost-effectiveness associated with different prostheses.

R Fitzpatrick;E Shortall;M Sculpher;D Murray.
Health Technology Assessment (1998)

1534 Citations

Representing uncertainty: the role of cost-effectiveness acceptability curves.

Elisabeth Fenwick;Karl Claxton;Mark Sculpher.
(2001)

1150 Citations

AN INTRODUCTION TO MARKOV MODELLING FOR ECONOMIC EVALUATION

Andrew Briggs;Mark Sculpher.
PharmacoEconomics (1998)

1000 Citations

Estimating mean QALYs in trial-based cost-effectiveness analysis : the importance of controlling for baseline utility

Andrea Manca;Neil Hawkins;Mark J. Sculpher.
Health Economics (2005)

841 Citations

Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold

Karl Philip Claxton;Stephen Martin;Marta O Soares;Nigel Rice.
Health Technology Assessment (2015)

813 Citations

Endovascular aneurysm repair and outcome in patients unfit for open repair of abdominal aortic aneurysm (EVAR trial 2): randomised controlled trial

R.M. Greenhalgh;L.C. Brown;D. Epstein;G.P.S. Kwong.
(2005)

779 Citations

Review of guidelines for good practice in decision-analytic modelling in health technology assessment

Z Philips;L Ginnelly;M Sculpher;K Claxton.
(2004)

744 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Mark Sculpher

Maarten J. Postma

Maarten J. Postma

University of Groningen

Publications: 130

Andrew Briggs

Andrew Briggs

University of Glasgow

Publications: 119

Michael Drummond

Michael Drummond

University of York

Publications: 110

Werner B. F. Brouwer

Werner B. F. Brouwer

Erasmus University Rotterdam

Publications: 102

John Brazier

John Brazier

University of Sheffield

Publications: 100

Peter J. Neumann

Peter J. Neumann

University of Bern

Publications: 72

M. G. Myriam Hunink

M. G. Myriam Hunink

Erasmus University Rotterdam

Publications: 67

Uwe Siebert

Uwe Siebert

UMIT TIROL - Private University for Health Sciences and Health Technology

Publications: 65

Julie Ratcliffe

Julie Ratcliffe

Flinders University

Publications: 63

Alastair Gray

Alastair Gray

University of Oxford

Publications: 63

Rod S Taylor

Rod S Taylor

University of Glasgow

Publications: 61

Martin Knapp

Martin Knapp

London School of Economics and Political Science

Publications: 61

Steven Simoens

Steven Simoens

KU Leuven

Publications: 60

Karl Claxton

Karl Claxton

University of York

Publications: 55

Ole Frithjof Norheim

Ole Frithjof Norheim

University of Bergen

Publications: 52

David J. Torgerson

David J. Torgerson

University of York

Publications: 52

Trending Scientists

Isabelle Sagnes

Isabelle Sagnes

Centre for Nanosciences and Nanotechnologies

Julio F. Davalos

Julio F. Davalos

City College of New York

Ovadia Lev

Ovadia Lev

Hebrew University of Jerusalem

Mary T. K. Arroyo

Mary T. K. Arroyo

University of Chile

Jeremy B. Searle

Jeremy B. Searle

Cornell University

Drazen B. Zimonjic

Drazen B. Zimonjic

National Institutes of Health

Nicolai V. Bovin

Nicolai V. Bovin

Russian Academy of Sciences

Malcolm J. McConville

Malcolm J. McConville

University of Melbourne

Benjamin K. Simpson

Benjamin K. Simpson

McGill University

John R. B. Lighton

John R. B. Lighton

University of Nevada, Las Vegas

Paul J. Kenny

Paul J. Kenny

Icahn School of Medicine at Mount Sinai

Jodi A. Quas

Jodi A. Quas

University of California, Irvine

Chris Roberts

Chris Roberts

University of Manchester

Simon Gilbody

Simon Gilbody

University of York

David A. Kass

David A. Kass

Johns Hopkins University School of Medicine

Lisa A. Eaton

Lisa A. Eaton

University of Connecticut

Something went wrong. Please try again later.